Welcome to LookChem.com Sign In|Join Free
  • or
N-cyclohexyl-N-methylpiperidin-4-amine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

754182-71-3

Post Buying Request

754182-71-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

754182-71-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 754182-71-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,5,4,1,8 and 2 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 754182-71:
(8*7)+(7*5)+(6*4)+(5*1)+(4*8)+(3*2)+(2*7)+(1*1)=173
173 % 10 = 3
So 754182-71-3 is a valid CAS Registry Number.

754182-71-3Downstream Products

754182-71-3Relevant academic research and scientific papers

Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety

Lv, Kai,Tao, Zeyu,Liu, Qian,Yang, Lu,Wang, Bin,Wu, Shuo,Wang, Apeng,Huang, Menghao,Liu, Mingliang,Lu, Yu

, p. 1 - 8 (2018)

We herein report the design and synthesis of benzothiazinones containing a piperidine moiety as new antitubercular agents based on the structure feature of IMB-ZR-1 discovered in our lab. Some of them were found to have good in vitro activity (MIC 1 μg/

NOVEL N-SULFAMOYL-PIPERIDINEAMIDES FOR THE PROPHYLAXIS OR TREATMENT OF OBESITY AND RELATED CONDITIONS

-

Page/Page column 37-38, (2010/11/27)

The present invention relates to novel N-sulfamoyl-piperidineamides of general formula (I) and their physiologically acceptable acid addition salts, to pharmaceutical compositions comprising them, processes for their preparation, and their use for the tre

N-Sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions

-

Page/Page column 16, (2010/11/27)

The present invention relates to novel N-sulfamoyl-piperidineamides of Formula I and their physiologically acceptable acid addition salts, to pharmaceutical compositions comprising them, processes for their preparation, and their use for the treatment of obesity and its concomitant and/or secondary diseases and related or other conditions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 754182-71-3